An 'in vivo' study was carried out in rats to evalutate the pharmacological activity and gastric tolerability of the 4-biphenylacetic acid (BFA) included in natural and modified cyclodextrins (Cds). A better bioavailability of orally administered drug is observed following inclusion, particularly in the presence of dimethylated cyclodextrin (DM-b-CD). A 50% reduction of the number of gastric lesions was observed with DM-b-CD at the highest administered dose with respect to free BFA.

In vivo study of inclusion of 4-biphenylacetic acid with cyclodextrins

Fresta M.;
1995-01-01

Abstract

An 'in vivo' study was carried out in rats to evalutate the pharmacological activity and gastric tolerability of the 4-biphenylacetic acid (BFA) included in natural and modified cyclodextrins (Cds). A better bioavailability of orally administered drug is observed following inclusion, particularly in the presence of dimethylated cyclodextrin (DM-b-CD). A 50% reduction of the number of gastric lesions was observed with DM-b-CD at the highest administered dose with respect to free BFA.
1995
4-biphenylacetic acid
biological studies
cyclodextrins
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12317/63723
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact